Buy Jubilant Life Sciences, target price Rs 867: Anand Rathi
The brokerage continues to remain positive on the company on a medium to longer term perspective and maintains a buy rating on the stock.from Markets-Economic Times https://ift.tt/3e7mFFu
The brokerage continues to remain positive on the company on a medium to longer term perspective and maintains a buy rating on the stock.from Markets-Economic Times https://ift.tt/3e7mFFu
Post a Comment